Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
7.60
-0.05 (-0.65%)
At close: Jun 3, 2026, 4:00 PM EDT
7.63
+0.03 (0.39%)
Pre-market: Jun 4, 2026, 8:06 AM EDT

ARCT Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
216174460846450976
Market Cap Growth
-33.57%-62.12%-45.64%87.82%-53.86%-14.10%
Enterprise Value
28.63-35.95247.79579.7988.71650.67
Last Close Price
7.606.1316.9731.5316.9637.01
PE Ratio
----48.46-
PS Ratio
3.952.123.025.072.1978.97
PB Ratio
1.130.811.913.041.674.28
P/TBV Ratio
1.100.791.903.021.704.27
P/FCF Ratio
----18.56-
P/OCF Ratio
----14.08-
EV/Sales Ratio
0.52-0.441.633.480.4352.65
EV/EBITDA Ratio
-0.49--6.47-
EV/EBIT Ratio
-0.47--7.28-
EV/FCF Ratio
-0.48--3.66-
Debt / Equity Ratio
0.100.100.100.090.110.20
Debt / EBITDA Ratio
----6.63-
Debt / FCF Ratio
----3.75-
Net Debt / Equity Ratio
-1.00-0.98-0.88-0.95-1.11-1.33
Net Debt / EBITDA Ratio
2.242.872.303.54-21.961.50
Net Debt / FCF Ratio
3.272.823.5112.67-12.402.19
Asset Turnover
0.210.270.390.380.490.03
Quick Ratio
6.196.503.683.953.113.76
Current Ratio
6.316.644.674.723.183.81
Return on Equity (ROE)
-25.51%-28.92%-31.16%-10.83%3.75%-65.20%
Return on Assets (ROA)
-34.21%-24.79%-24.74%-18.95%2.54%-46.67%
Return on Invested Capital (ROIC)
-238.55%-154.04%-118.61%-70.46%9.90%-376.23%
Return on Capital Employed (ROCE)
-39.64%-29.71%-30.57%-23.32%3.95%-56.33%
Earnings Yield
----2.06%-
FCF Yield
----5.39%-
Buyback Yield / Dilution
-2.43%-1.43%-1.40%1.72%-2.95%-11.83%
Total Shareholder Return
-2.43%-1.43%-1.40%1.72%-2.95%-11.83%
SEC Filings: 10-K · 10-Q